Segal Trials

Posts by:

Segal Trials

psychedelics research

Psychedelics Substance: The History & Future

Psychedelics have been used for centuries in spiritual and medicinal settings, but only recently have they begun to gain acceptance in the scientific community. Research on psychedelics such as LSD, psilocybin, and MDMA is expanding rapidly, with promising findings in treatments for mental health disorders like depression, anxiety, and PTSD, to name a few. 

Read More

Clinical Trials for Mental Illnesses: Demystified

Clinical research is how all treatments reach patients, including medications to treat mental illnesses. All medications currently on the market went through the rigorous stages of the clinical research funnel, and many more are currently being researched. To date, Segal Trials has 57 medications and devices that are approved by the U.S. Food and Drug Administration (FDA). That’s 57 treatments changing the lives of millions of patients. 

Read More
General Anxiety Disorder Clinical Trial Study

Mental Health Awareness: General Anxiety Disorder

Our focus for 2023 is to raise mental health awareness and to keep a stream of constant communication flowing. 

Raising mental health awareness is an important social issue that needs to be addressed. Conversations encourage people to talk about mental health issues and to know it's completely normal to seek help - if needed. Mental health awareness also helps to reduce the stigma associated with seeking mental health services. When we talk about mental health, we create an environment where people feel safe and supported to talk about their mental health, allowing easier access to services and a better understanding of the needs of individuals experiencing mental health issues.

Read More
Clinical Research Studies for Depression

We Chose a Clinical Trial for Depression and Here's Why

Major depressive disorder (MDD) or Depression is often described as having a loss of interest in daily activities and feeling hopeless. As discussed in our previous blog with Dr. Kakar, A Board Certified Psychiatrist Shares Surprising Facts About Depression, while those are common symptoms, depression varies by every individual. Depression varies by treatments, triggers, and the impact of MDD on a person’s life. In this blog, we’re unpacking those differences and sharing patients’ insights on clinical trials. 

Read More

A Board Certified Psychiatrist Shares Surprising Facts About Depression

 

Depression is often thought of as feeling sad. While sadness is a symptom, depression is more complex than people may realize. In an interview with Segal Trials’ Chief Scientific Officer and Medical Director, Dr. Rishi Kakar, MD unpacked the interconnected causes, symptoms, and treatments of depression. In brief, “When you know someone with depression, you only know one depression,” Dr. Kakar stated. Below are the top facts and statistics Dr. Kakar shared about depression that may surprise you.

Read More